Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives [Yahoo! Finance]
Aethlon Medical, Inc. (AEMD)
NASDAQ:AMEX Investor Relations:
ir.aethlonmedical.com
Company Research
Source: Yahoo! Finance
therapies to address cardiovascular disease and cancer, today released the following shareholder update authored by Chief Executive Officer, Jim Joyce. Dear Shareholders and Interested Parties, Prior to our formation of Sigyn Therapeutics, I was the founder of Aethlon Medical and oversaw the development of the Aethlon HemopurifierTM from concept to becoming the first therapy to receive multiple FDA "Breakthrough Device" designations and first medical device cleared by FDA to treat a pandemic virus. TIME magazine named the HemopurifierTM a "Top 25 Invention" and a "Top Eleven Medical Breakthrough." During my tenure, Aethlon became Nasdaq-listed and had a peak-market value of approximately $200 million. At Sigyn Therapeutics, we have developed CardioDialysisTM to address relevant therapeutic targets underlying a wide range of life-threatening disease conditions. These include clinically significant drivers of cardiovascular disease (leading cause of death worldwide), as well as re
Show less
Read more
Impact Snapshot
Event Time:
AEMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AEMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AEMD alerts
High impacting Aethlon Medical, Inc. news events
Weekly update
A roundup of the hottest topics
AEMD
News
- Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic OpportunitiesPR Newswire
- Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical to Present at the Life Sciences Investor Forum on March 12thGlobeNewswire
- Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 [Yahoo! Finance]Yahoo! Finance
AEMD
Earnings
- 2/12/26 - Miss
AEMD
Sec Filings
- 3/17/26 - Form 8-K
- 2/23/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- AEMD's page on the SEC website